| Literature DB >> 19523217 |
Marie-Claude F Jaurand1, Annie Renier, Julien Daubriac.
Abstract
Carbon nanotubes (CNTs), the product of new technology, may be used in a wide range of applications. Because they present similarities to asbestos fibres in terms of their shape and size, it is legitimate to raise the question of their safety for human health. Recent animal and cellular studies suggest that CNTs elicit tissue and cell responses similar to those observed with asbestos fibres, which increases concern about the adverse biological effects of CNTs. While asbestos fibres' mechanisms of action are not fully understood, sufficient results are available to develop hypotheses about the significant factors underlying their damaging effects. This review will summarize the current state of knowledge about the biological effects of CNTs and will discuss to what extent they present similarities to those of asbestos fibres. Finally, the characteristics of asbestos known to be associated with toxicity will be analyzed to address the possible impact of CNTs.Entities:
Year: 2009 PMID: 19523217 PMCID: PMC2706793 DOI: 10.1186/1743-8977-6-16
Source DB: PubMed Journal: Part Fibre Toxicol ISSN: 1743-8977 Impact factor: 9.400
Summary of recent in vivo experiments carried out with CNTs
| Type of CNT | System | Summary results | Reference |
| SWCNTs | Pharyngeal deposition in C57Bl/6 mice lung (40 μg/mouse). Observation 4 hours post exposure. | Gene expression in lung and blood: Upregulation of genes involved in inflammation, oxidative stress, coagulation, tissue remodeling. Increased percentage of polymorphonuclear leucocytes (PMN) in blood and bronchoalveolar lavage (BAL). | [ |
| SWCNTs. | Inhalation (4 days) in mice – 5 mg/m3 | Lung analysis: Inflammation – Granulomas – Fibrosis – Mutation of K- | [ |
| 4.2 μm (mode, aerodynamic diameter; in mass) | Laryngeal deposition (10 μg/mouse). | Lung analysis: Inflammation – Granulomas – Fibrosis - | |
| MWCNTs. | Intratracheal deposition in rats. | Inflammation; dose-dependent thickening of the alveolar lining | [ |
| MWCNTs grinded, unheated, heated to 600°C, 2400°C; 2400°C then grinded. | Intratracheal deposition in rats, 2 mg/rat. Short-term response (3 days); mean-term (60 days) | Inflammation (3 days). Granulomas (60 days). | [ |
| MWCNTs. | Intratracheal deposition in rats. One to 7 mg/kg. Short/mean term responses (1 to 90 days) | Inflammation; dose-dependent thickening of the alveolar lining | [ |
| MWCNTs | Pharyngeal deposition in C57Bl/6 mice lung (40 μg/mouse). Observation 4 hours post exposure. | Gene expression in lung and blood: Upregulation of genes involved in inflammation, oxidative stress, coagulation, tissue remodeling. Increased percentage of polymorphonuclear leucocytes (PMN) in blood and bronchoalveolar lavage (BAL). | [ |
| MWCNTs | Inhalation (≈ 32 mg/m3) in mice for 5, 10, 15 days; deposition ≈ 0.07, 0.14; 0.24 μg/mouse. Short-term response (8, 16, 24 days) | Small aggregates entering the alveolar wall | [ |
| Tracheal deposition: 50 μg/mouse | Eight and 16 days: clumps deposited on lining wall of bronchi, no inflammation – 24 days: inflammation. | ||
Summary of recent in vitro experiments carried out with CNTs
| Type of CNT | System | Summary results | Reference |
| SWCNTs (HiPco), (CNI Inc.). | Lung hamster fibroblasts (V79) | Cytotoxicity (time and dose dependent) | [ |
| SWCNTs (50% SWCNT, about 40% other nanotubes). | BEAS 2B human bronchial epithelial cells | Dose-dependent decrease in cell viability. Dose-dependent DNA damage. No formation of micronuclei | [ |
| SWCNTs (NIST) | Normal human mesothelial cells and human mesothelioma cell line | Cell death. DNA lesions | [ |
| SWCNTs. Folate conjugated. | HepG2 cells (express folate receptor) | No toxicity if < 50 μg/ml. Dose-dependent apoptosis. Kinetics of SWCNT internalisation: Mb → cytoplasm → extracellular | [ |
| SWCNTs (HiPco) | Human lung epithelial cells A549 and immortalised NHBE | Decreased inflammatory response in TNF alpha-stimulated cells | [ |
| SWCNTs Mitsui & Co., Ltd | Human aortic endothelial cells | Internalisation: CNTs identified in the cytoplasm. Cytotoxicity. IL-8 release. Actin filament and Ecadherin disruption. Reduced tubule formation. | [ |
| SWCNTs | Mouse embryo fibroblasts | Low cytotoxicity. DNA damage (comet assay) | [ |
| MWCNTs. | Mouse macrophages (J774.1). | No MAPKs activation; no apoptosis. | [ |
| MWCNTs. | Human epithelial cells (MCF-7) | Chromosomal aberrations (micronuclei) showing chromosome breakage and loss of whole chromosomes | [ |
| MWCNTs (C100, Arkema). | Human epithelial (A549) and Large T SV40 transformed mesothelial (Met-5A) cells | Decrease in cell viability (mitochondrial alteration) without apoptosis. No oxidative stress. No MWCNT internalisation | [ |
| MWCNTs grinded, unheated, heated to 600°C, 2400°C; 2400°C then grinded. | Rat lung epithelial cells. | Chromosomal aberrations (micronuclei) | [ |
| MWCNTs. | Human epithelial cells (A549) | DNA breakage (comets). | [ |
| MWCNTs | Mouse embryonic cells (ES) | P53 activation. Induction of DNA repair. | [ |
| MWCNTs Mitsui & Co., Ltd | Human aortic endothelial cells | Cytotoxicity. IL-8 release. Actin filament and Ecadherin disruption. Reduced tubule formation. | [ |
| MWCNTs | Human pneumocytes A549 | Decrease in cell viability | [ |
Summary of in vitro experiments related to gene expression in crocidolite-treated mesothelial cells
| System | Summary results | Reference |
| Human mesothelial cells (LP9/TERT-1) exposed to low and high concentrations (15 and 75 μm2/cm2 per dish) for 8 or 24 h | ATF3-dependent modulation of inflammatory cytokines and growth factor production | [ |
| Human SV40-immortalized pleural mesothelial (MeT-5A) cells exposed to 1 μg/cm2 dish for 1–48 h | 1 h: upregulation of nucleosome assembly, translational initiation, transcription, I-kappaB kinase/NF-kappaB cascade, survival | [ |
| Normal rat pleural mesothelial cells exposed to 5 μg/cm2 dish for 24 h | Induction of fra-1-linked cd44 and c-met expression | [ |
Comparison between physical and chemical parameters of asbestos and CNTs
| Shape | Both are elongated particles; fibre shaped. |
| Dimensions | Asbestos fibre diameter: range of 100 nm. Chrysotile fibrils: ≅ 50 nm of diameter. Same order as MWCNTs. |
| Structure | Chrysotile: multi-layered rolled sheets of brucite (MgOH2) and silicon oxide (SiO2). Important aggregation with CNTs, which may form more entangled bundles, ropes, than asbestos. |
| Chemistry | Different chemistry. Possibility of metal impurities in both asbestos and CNTs. |
| Surface reactivity | Both show sorptive properties to biological molecules. ROS production: no definitive answer for CNTs. |
Comparison between biological effects of asbestos and CNTs
| Particle uptake | Demonstrated with both types. Conflicting results with CNTs. Exocytosis found with CNTs, so far not investigated with asbestos. |
| Cytotoxicity | Both cytotoxic. |
| DNA damage, mutation, gene interaction | Found with both asbestos and CNTs. |
| Transfection | Gene transfer is with asbestos. CNT gene knockdown. |
| Biodistribution | Both types are cleared |
| Inflammation, granulomas, fibrosis | Found with both asbestos and CNTs. Both types show dependence of biological effects with fibre dimensions: bioactivity of long fibres. |
| Cancer | MM found with both asbestos and CNTs by peritoneal exposure. |